361 Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-53,758
Closed -$1.24M 332
2017
Q4
$1.24M Sell
53,758
-28,630
-35% -$593K 0.31% 172
2017
Q3
$1.73M Buy
82,388
+6,914
+9% +$127K 0.33% 164
2017
Q2
$1.52M Sell
75,474
-9,478
-11% -$206K 0.26% 121
2017
Q1
$2.06M Buy
+84,952
New +$2.29M 0.44% 75

Other funds holding PTEN

361 Capital's PTEN Position: Q1 2018 in Review

361 Capital sold out of Patterson-UTI (PTEN) in Q1 2018, closing a stake of 53,758 shares — an estimated $1.24M sold.

361 Capital first reported a position in PTEN in Q1 2017 and held it in 4 quarters. The position peaked at $2.06M in Q1 2017. 327 funds tracked by Wall St. Rank hold PTEN as of Q1 2018.

  • 361 Capital reported no remaining Patterson-UTI position as of Q1 2018 after selling out during the quarter.
  • 361 Capital sold 53,758 Patterson-UTI shares in Q1 2018, an estimated $1.24M.
  • 361 Capital first reported a position in Patterson-UTI in Q1 2017 and held it in 4 quarters.
  • 361 Capital's Patterson-UTI position peaked at $2.06M in Q1 2017.
  • 327 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.